Metabolic sarcopenia in the era of incretin-based therapy: a narrative review of mitochondrial determinants of muscle quality and emerging therapeutic strategies

More on GLP-1 and incretin signalling

• Inotodiol preserves muscle mass and function in aged mice

  Signal Transduction and Targeted Therapy · 3 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• Survodutide reduces weight in adults with diabetes and obesity

  The New England Journal of Medicine · 4 Oct 2026

• Mitochondrial proteostasis is impaired in mouse heart failure

  American Journal of Physiology Heart and Circulatory Physiology · 3 Oct 2026